Shares of Moderna Inc. MRNA rose 1.55% to $70.55 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.87% to 11,117.53 and the Dow Jones Industrial Average DJIA rising 1.51% to 27,584.06. This was the stock's second consecutive day of gains. Moderna Inc. closed $24.66 short of its 52-week high ($95.21), which the company reached on July 17th.
The stock outperformed some of its competitors Monday, as AbbVie Inc. ABBV rose 1.22% to $87.28 and Amgen Inc. AMGN rose 1.32% to $247.03. Trading volume (7.3 M) remained 8.4 million below its 50-day average volume of 15.7 M.